×
To start your customized experience click the start button
Customize ?  
Start
Cancer Types
Quick Links
Award Programs
About Us
Careers
Contact Us
Newsroom
Privacy Policy
Terms & Conditions
 
Twitter
Face Book
YouTube
Instagram
 
 
Cure Media Group, LLC.
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 800-210-2873

Copyright © 2018
CURE Media Group.
All rights reserved.
Cure Media Group, LLC. All Rights Reserved.
CURE does not provide medical, diagnostic, or treatment advice.

Childhood Cancers

Beth Fand Incollingo
The Childhood Solid Tumor Network at St. Jude is helping scientists inside and outside the hospital’s walls to expand treatment options for youngsters with these cancers.
Alexandra Guadagno
From FDA news to today’s top performers and entertainers, here’s what’s making headlines in the cancer space this week.
Beth Fand Incollingo
St. Jude Children’s Research Hospital is offering cloud-based access to the fully sequenced genomes of 10,000 pediatric patients with cancer, in the hopes that sharing the information will lead to the highest possible number of treatment breakthroughs.
Katie Kosko
Productivity loss among parent caregivers associated with poor health-related quality of life in pediatric advanced stage Hodgkin lymphoma. 
The V Foundation
Event to Fund Cutting-Edge Pediatric Cancer Research
Brielle Benyon
President Donald J. Trump announced his plan to amp up the fight against childhood cancer, and to lower prescription drug costs.
Brielle Benyon
Certain groups of pediatric and adolescent patients are less likely to receive fertility preservation consultation, recent research says.
Kristie L. Kahl
This week, we spoke with the co-founder of a nonprofit organization dedicated to funding research to eliminate childhood cancer, as well as two families who have benefitted from the research being done in this area.
Brielle Benyon
The Food and Drug Administration (FDA) approved Sprycel (dasatinib) plus chemotherapy for the treatment of pediatric patients with newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia
Beth Fand Incollingo
AN ANTIOXIDANT APPROVED FOR use as an antidote to cyanide poisoning may also prevent hearing loss, a potential side effect of the chemotherapy drug cisplatin, in children who take the anticancer drug.
 
×
×

Sign In

Not a member? Sign up now!
Continue without login
Continue
×

Sign Up

Patient Caregiver Advocate Other